The approval of novel orphan drug designations continues to grow, while many existing rare disease therapies are receiving approval for expanded indications.…

Tresiba

UPDATED: U.S. payer pressures force Novo Nordisk to cut loose 1,000 staffers

Novo Nordisk says new drugs Tresiba, Ryzodeg will claw back lost market share in China